CAS: 80996-23-2 - (1S)-5,12-dihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,6,11-tetrahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
Fórmula:C27H27NO10
InChI:InChI=1/C27H27NO10/c1-10-23(31)14(28)8-18(37-10)38-17-7-11(15(30)9-29)6-13-20(17)27(35)22-21(25(13)33)24(32)12-4-3-5-16(36-2)19(12)26(22)34/h3-6,10,14,17-18,23,29,31,33,35H,7-9,28H2,1-2H3/t10-,14-,17-,18-,23+/m0/s1
- Sinónimos:
- 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-9,10-dihydro-6,11-dihydroxy-8-(hydroxyacetyl)-1-methoxy-, (S)-
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 9,10-Anhydro doxorubicin REF: 7W-GC2955CAS: 80996-23-2 | - - - | A consultar | Vie 03 May 24 |
 | Doxorubicin Impurity 8 (9,10-Anhydro Doxorubicin) REF: 4Z-D-3423CAS: 80996-23-2 | - - - | A consultar | Jue 09 May 24 |
Ref: 7W-GC2955
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
Doxorubicin Impurity 8 (9,10-Anhydro Doxorubicin)
CAS:80996-23-2
Fórmula:
C27H27NO10
Peso molecular:
525.52
Ref: 4Z-D-3423
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
